Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-26-006375
Filing Date
2026-06-22
Accepted
2026-06-22 16:44:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 4323
  Complete submission text file 0001950047-26-006375.txt   5872
Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

EIN.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37722 | Film No.: 261107693
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 421 KIPLING STREET PALO ALTO CA 94301
Business Address
HENDERSON MICHAEL THOMAS (Reporting) CIK: 0001779990 (see all company filings)

Type: 144